Unknown

Dataset Information

0

A redox switch regulates the structure and function of anti-apoptotic BFL-1.


ABSTRACT: Apoptosis is regulated by BCL-2 family proteins. Anti-apoptotic members suppress cell death by deploying a surface groove to capture the critical BH3 ?-helix of pro-apoptotic members. Cancer cells hijack this mechanism by overexpressing anti-apoptotic BCL-2 family proteins to enforce cellular immortality. We previously identified and harnessed a unique cysteine (C55) in the groove of anti-apoptotic BFL-1 to selectively neutralize its oncogenic activity using a covalent stapled-peptide inhibitor. Here, we find that disulfide bonding between a native cysteine pair at the groove (C55) and C-terminal ?9 helix (C175) of BFL-1 operates as a redox switch to control the accessibility of the anti-apoptotic pocket. Reducing the C55-C175 disulfide triggers ?9 release, which promotes mitochondrial translocation, groove exposure for BH3 interaction and inhibition of mitochondrial permeabilization by pro-apoptotic BAX. C55-C175 disulfide formation in an oxidative cellular environment abrogates the ability of BFL-1 to bind BH3 domains. Thus, we identify a mechanism of conformational control of BFL-1 by an intramolecular redox switch.

SUBMITTER: Korshavn KJ 

PROVIDER: S-EPMC7544158 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

A redox switch regulates the structure and function of anti-apoptotic BFL-1.

Korshavn Kyle J KJ   Wales Thomas E TE   Bird Gregory H GH   Engen John R JR   Walensky Loren D LD  

Nature structural & molecular biology 20200713 9


Apoptosis is regulated by BCL-2 family proteins. Anti-apoptotic members suppress cell death by deploying a surface groove to capture the critical BH3 α-helix of pro-apoptotic members. Cancer cells hijack this mechanism by overexpressing anti-apoptotic BCL-2 family proteins to enforce cellular immortality. We previously identified and harnessed a unique cysteine (C55) in the groove of anti-apoptotic BFL-1 to selectively neutralize its oncogenic activity using a covalent stapled-peptide inhibitor.  ...[more]

Similar Datasets

2020-06-17 | PXD016059 | Pride
| S-EPMC9674691 | biostudies-literature
| S-EPMC5055752 | biostudies-literature
| S-EPMC7405809 | biostudies-literature
| S-EPMC3690303 | biostudies-literature
| S-EPMC5947960 | biostudies-literature
| S-EPMC5399193 | biostudies-literature
| S-EPMC8490995 | biostudies-literature
| S-EPMC4051499 | biostudies-literature
| S-EPMC5464773 | biostudies-literature